RECENT PRESS
2012
Natera to Present Update About Development, Commercialization of Non-Invasive Prenatal Diagnostic Test at the Citi 2012 Global Health Care Conference
February, 2012
Natera’s Non-Invasive Prenatal Diagnostic to Detect Down Syndrome, Trisomy 13, Trisomy 18 and Certain Sex Chromosome Abnormalitiesin the First Trimester of Pregnancy
February, 2012
Gene Security Network Announces Completion of $20 Million Financing Round, Change of Company Name to Natera
January, 2012
2011
Gene Security Network Launches First Non-Invasive Prenatal Test Powered by Company’s Bioinformatics Technology
August, 2011
Gene Security Network Receives $2M Grant from NIH to Fund Clinical Trial to Apply Parental Support ™ for Non-invasive Prenatal Diagnosis
April, 2011
GSN’s Testing Technology Helps Couple Achieve Their Dream of a Healthy Child
April, 2011
Gene Security Network Highlighted by Dr. Givens from Pacific Fertility Center
February, 2011
2010
Gene Security Network Completes Funding to Expand into New DNA Testing Markets – $12M Series C Financing Led by Sequoia Capital
November, 2010
Gene Security Network Announces Launch of Clinical Trial to Test Preimplantation Genetic Diagnosis (PGD) Technology in Partnership with Ferring Pharmaceuticals
October, 2010
Gene Security Network Publishes Article in the Journal of Clinical Embryology Comparing Existing PGD Technologies
April, 2010
Gene Security Network and Ferring Pharmaceuticals Partner To Test Advanced Preimplantation Genetic Diagnosis (PGD) Technology
February, 2010
Breakthrough Study Demonstrating Superior Accuracy of GSN’s Parental Support for Preimplantation Genetic Screening Published in Human Reproduction
February, 2010
2009
Gene Security Network Names Jason Nestor Vice President of Sales
October, 2009
First Babies Born After Use of GSN’s 24 Chromosome Aneuploidy Screening
July, 2009
Gene Security Network Completes $6M Series B Financing
January, 2009